Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Becton Dickinson & Company: División de Sistemas VACUTAINER (Resumido)
Cespedes, Frank V.; Rangan, V. KasturiCaso HBS-502S25MarketingBecton Dickinson, una empresa fenomenalmente exitosa con una cuota de mercado 80% en el mercado de las agujas de recogida de sangre y jeringas se enfrenta a un cambio en el entorno de compra del cliente (presiones de contención de costos en los hospitales). Esto obliga a una reevaluación de la empresa es altamente exitosa política de producto y estrategia de canal. Uno de los principales clientes de la compañía amenaza con dejarlos por negarse a ...Desde 8,20 €
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCaso HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Desde 8,20 €
-
Ring Medical (Spanish version)
Rangan, V. Kasturi; Fay, ChristopherCaso HBS-520S11MarketingDescribes the progress of a new product launch (HCS-100, a hospital communication system). Ring Medical has sold only five systems in six months against an annual target of 30. There is a lack of agreement internally on how the new product effort should be organized. In addition, there are differences of opinion on which distribution channels are most appropriate. These issues must be resolved before the board meeting scheduled for the following ...Desde 8,20 €
-
New Product Marketing Strategy (Spanish version)
Rangan, V. Kasturi; Lasley, SusanCaso HBS-502S09MarketingJoan Macey, Rohm and Haas' market manager for Metalworking Fluid Biocides, found that sales of a new biocide, Kathon MWX, was utterly disappointing. This was all the more puzzling since sales of her other product--Kathon 886 MW, a liquid biocide used only in large-capacity tanks--was well on target and held a steady 30% market share. In May 1984, about five months after the new product was launched, Joan Macey was reviewing her entire marketing s...Desde 8,20 €
-
Los Nuevos Horizontes de Dell
Rangan, V. Kasturi; Bell, MarieCaso HBS-503S30MarketingFundada en 1984, Dell Corp. ha logrado un crecimiento fenomenal, y para 2000 había superado los $ 25 mil millones en ventas y más de $ 2 mil millones en ingresos netos. En el cuarto trimestre de 2000, sin embargo, la tasa de crecimiento promedio de 30 años de la industria del PC se estrelló a un negativo del 10%. Dell debe tomar decisiones difíciles sobre cómo mantener su rentabilidad a la luz de su amplia cartera de productos - PC, estaciones de...Desde 8,20 €
-
The Coming Battle over Executive Pay
Dillon, KarenArtículo HBS-R0909L-ELiderazgo y Dirección de personasWall Street may have ignited the outrage over executive compensation, but it's now affecting all public companies. Believing that corporate pay practices encourage excessive risk taking, policy makers feel compelled to intervene, and shareholders are angrily demanding input. The battle will rage in boardrooms and annual meetings for years, and it won't be pretty. A bill that will give shareholders a "say on pay" is winding through Congress, and i...Desde 8,20 €
-
"I Think of My Failures as a Gift"
Lafley, A.G.; Dillon, KarenArtículo HBS-R1104F-ELafley, the former CEO of Procter & Gamble, is regarded as one of the most successful chief executives in recent history. But like everyone else, he's had his share of mistakes. Politicians and winning sports teams draw their biggest lessons from their toughest losses, he says, and the same has been true for him. The company learned more from its failed new brands and products than from its successes. Among Lafley's favorite examples is the color...Desde 8,20 €